Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nora Hagelberg

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|August 7, 2015
[Can we prevent pain becoming chronic?]Nora Hagelberg, Maija Haanpää
Pain|July 23, 2020
Machine learning suggests sleep as a core factor in chronic painTeemu Miettinen, Pekka Mäntyselkä, Nora Hagelberg, et al.
European Journal of Pharmacology|July 24, 2018
Dopaminergic and serotonergic mechanisms in the modulation of pain: In vivo studies in human brainIlkka K Martikainen, Nora Hagelberg, Satu K Jääskeläinen, et al.
Synapse (New York, N.Y.)|July 12, 2002
Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in manNora Hagelberg, Jaana K Kajander, Kjell Någren, et al.
Neuroscience Letters|February 22, 2005
Association of striatal dopamine D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesiaIlkka K Martikainen, Nora Hagelberg, Heikki Mansikka, et al.
Antimicrobial Agents and Chemotherapy|December 22, 2010
Miconazole oral gel increases exposure to oral oxycodone by inhibition of CYP2D6 and CYP3A4Juha Grönlund, Teijo I Saari, Nora Hagelberg, et al.
The European Journal of Neuroscience|September 10, 2004
Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to painAntti Pertovaara, Ilkka K Martikainen, Nora Hagelberg, et al.
Pain|July 18, 2017
Validation of EQ-5D and 15D in the assessment of health-related quality of life in chronic painPekka Vartiainen, Pekka Mäntyselkä, Tarja Heiskanen, et al.
Molecular Imaging and Biology|October 2, 2009
COMT Val158Met genotype does not alter cortical or striatal dopamine D2 receptor availability in vivoMika M Hirvonen, Kjell Någren, Juha O Rinne, et al.
Medicine|November 19, 2016
The analgesic effect of therapeutic rTMS is not mediated or predicted by comorbid psychiatric or sleep disordersPauliina Lindholm, Salla Lamusuo, Tero Taiminen, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Duodecim; Laaketieteellinen Aikakauskirja|August 7, 2015
[Can we prevent pain becoming chronic?]Nora Hagelberg, Maija Haanpää
Pain|July 23, 2020
Machine learning suggests sleep as a core factor in chronic painTeemu Miettinen, Pekka Mäntyselkä, Nora Hagelberg, et al.
European Journal of Pharmacology|July 24, 2018
Dopaminergic and serotonergic mechanisms in the modulation of pain: In vivo studies in human brainIlkka K Martikainen, Nora Hagelberg, Satu K Jääskeläinen, et al.
Synapse (New York, N.Y.)|July 12, 2002
Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in manNora Hagelberg, Jaana K Kajander, Kjell Någren, et al.
Neuroscience Letters|February 22, 2005
Association of striatal dopamine D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesiaIlkka K Martikainen, Nora Hagelberg, Heikki Mansikka, et al.
Antimicrobial Agents and Chemotherapy|December 22, 2010
Miconazole oral gel increases exposure to oral oxycodone by inhibition of CYP2D6 and CYP3A4Juha Grönlund, Teijo I Saari, Nora Hagelberg, et al.
The European Journal of Neuroscience|September 10, 2004
Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to painAntti Pertovaara, Ilkka K Martikainen, Nora Hagelberg, et al.
Pain|July 18, 2017
Validation of EQ-5D and 15D in the assessment of health-related quality of life in chronic painPekka Vartiainen, Pekka Mäntyselkä, Tarja Heiskanen, et al.
Molecular Imaging and Biology|October 2, 2009
COMT Val158Met genotype does not alter cortical or striatal dopamine D2 receptor availability in vivoMika M Hirvonen, Kjell Någren, Juha O Rinne, et al.
Medicine|November 19, 2016
The analgesic effect of therapeutic rTMS is not mediated or predicted by comorbid psychiatric or sleep disordersPauliina Lindholm, Salla Lamusuo, Tero Taiminen, et al.
Pageof 3